Medtronic plc (MDT)
NYSE · Healthcare · Medical - Devices
Profile
Medtronic plc
- Exchange
- NYSE
- Ticker
- MDT
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- IE
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
Key facts
Medtronic plc: key facts
- Medtronic plc (NYSE: MDT) is a Medical - Devices company in the Healthcare sector.
- In fiscal 2026, Medtronic plc reported revenue of $36.4B and net income of $4.8B.
- Revenue grew 3.5% a year over the last 4 fiscal years.
- Free cash flow was positive in 5 of the last 5 fiscal years.
- Net income was positive in 5 of the last 5 fiscal years.
- Over the last twelve months, revenue was $37.5B and net income was $5.2B.
MonkScore
Medtronic plc's MonkScore
MonkScore
MonkScore range: 30–40
as of October 2026
Sector rank: 441 of 628 in Healthcare
How this score is madeDisclaimer
Pillar ranges
- Growth10–20
- Profitability30–40
- Quality80–90
- Market Conviction30–40
- Safety30–40
The MonkScore runs from 0 to 100. Each range is one of ten 10-point groups, from 0–10 to 90–100.
Each pillar's range uses the same ten groups. The exact score and the pillar scores are in the MonkStreet app.
Fundamentals
Figures from the statements
Medtronic plc's annual figures and the last twelve months, in USD. Last report: 31 July 2026.
| Figure | Last 12 months | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Revenue | $37.5B | $36.4B | $33.5B | $32.4B | $31.2B | $31.7B |
| Gross profit | $25.0B | $23.6B | $21.9B | $21.1B | $20.5B | $21.5B |
| Operating income | $6.8B | $6.5B | $6.0B | $5.1B | $5.5B | $5.8B |
| Net income | $5.2B | $4.8B | $4.7B | $3.7B | $3.8B | $5.0B |
| Operating cash flow | $8.0B | $7.3B | $7.0B | $6.8B | $6.0B | $7.3B |
| Capital expenditure | -$1.9B | -$1.9B | -$1.9B | -$1.6B | -$1.5B | -$1.4B |
| Free cash flow | $6.1B | $5.4B | $5.2B | $5.2B | $4.6B | $6.0B |
| Total debt | $28.2B | $28.0B | $28.5B | $25.0B | $24.4B | $24.1B |
| Cash | $1.7B | $1.9B | $2.2B | $1.3B | $1.5B | $3.7B |
Revenue growth a year
- 1-year
- 8.4%
- 3-year
- 5.2%
- 4-year
- 3.5%
Compound growth between fiscal years.
Peers
Similar companies
- Sight Sciences, Inc.NASDAQ:SGHTMonkScore range: 30–40
- Orthofix Medical Inc.NASDAQ:OFIXMonkScore range: 40–50
- Establishment Labs Holdings Inc.NASDAQ:ESTAMonkScore range: 40–50
- Boston Scientific CorporationNYSE:BSXMonkScore range: 40–50
- Tandem Diabetes Care, Inc.NASDAQ:TNDMMonkScore range: 40–50
- Butterfly Network, Inc.NYSE:BFLYMonkScore range: 50–60
- Neogen CorporationNASDAQ:NEOGMonkScore range: 50–60
- Align Technology, Inc.NASDAQ:ALGNMonkScore range: 50–60
Score my top stocks · 14-day free trial · card required · not charged during the trial · cancel in one click
MonkStreet provides research, not investment advice.
Page built on 31 October 2026.